Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-126343
Filing Date
2024-11-13
Accepted
2024-11-13 16:17:03
Documents
44
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q mnov-20240930.htm   iXBRL 10-Q 1004170
2 EX-31.1 mnov-ex31_1.htm EX-31.1 13800
3 EX-31.2 mnov-ex31_2.htm EX-31.2 14204
4 EX-32.1 mnov-ex32_1.htm EX-32.1 9755
5 EX-32.2 mnov-ex32_2.htm EX-32.2 9826
  Complete submission text file 0000950170-24-126343.txt   4141597

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT mnov-20240930.xsd EX-101.SCH 642782
47 EXTRACTED XBRL INSTANCE DOCUMENT mnov-20240930_htm.xml XML 550783
Mailing Address 4275 EXECUTIVE SQUARE SUITE 300 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 300 LA JOLLA CA 92037 858-373-1500
MEDICINOVA INC (Filer) CIK: 0001226616 (see all company filings)

IRS No.: 330927979 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33185 | Film No.: 241454516
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)